AG˹ٷ

STOCK TITAN

[Form 4] Lifevantage Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Julie Boyster, identified as an Officer (Chief Marketing Officer), reported Section 16 transactions in Lifevantage Corp (LFVN) on 08/31/2025. Two grants of Performance Restricted Stock Units (PRSUs) converted or vested resulting in acquisitions: 18,934 shares (from a PRSU grant on 08/24/2023) and 27,966 shares (from a PRSU grant on 08/26/2024). The filing states PRSUs convert into common stock on a one-for-one basis. The holder also reported a disposition of 23,293 shares at a price of $13.10 each. Following the reported transactions, the form shows the reporting person beneficially owned 151,923 shares directly. The form is signed by a power of attorney on behalf of Julie Boyster.

Julie Boyster, indicata come Officer (Chief Marketing Officer), ha segnalato operazioni ai sensi della Section 16 per Lifevantage Corp (LFVN) in data 08/31/2025. Due concessioni di Performance Restricted Stock Units (PRSUs) sono state convertite o sono maturate, determinando acquisizioni di: 18.934 azioni (da una PRSU concessa il 08/24/2023) e 27.966 azioni (da una PRSU concessa il 08/26/2024). Il modulo indica che le PRSU si convertono in azioni ordinarie al rapporto di uno a uno. La titolare ha inoltre segnalato la cessione di 23.293 azioni a un prezzo di $13.10 ciascuna. A seguito delle operazioni riportate, il modulo mostra che la persona che effettua la segnalazione possedeva direttamente 151.923 azioni. Il documento è firmato da un procuratore per conto di Julie Boyster.

Julie Boyster, identificada como Officer (Chief Marketing Officer), informó transacciones bajo la Section 16 en Lifevantage Corp (LFVN) el 08/31/2025. Dos concesiones de Performance Restricted Stock Units (PRSUs) se convirtieron o vencieron, resultando en adquisiciones de: 18.934 acciones (de una PRSU otorgada el 08/24/2023) y 27.966 acciones (de una PRSU otorgada el 08/26/2024). La declaración indica que las PRSU se convierten en acciones ordinarias en una proporción de uno a uno. La titular también reportó una disposición de 23.293 acciones a un precio de $13.10 cada una. Tras las transacciones notificadas, el formulario muestra que la persona informante poseía directamente 151.923 acciones. El formulario está firmado por un apoderado en nombre de Julie Boyster.

Julie BoysterOfficer (Chief Marketing Officer)� 확인되었으며, 08/31/2025� Lifevantage Corp (LFVN)� 대� Section 16 거래� 신고했습니다. � 건의 퍼포먼스 제한 주식 단위(PRSUs)가 전환되거� 베스팅되� 다음� 같은 취득� 발생했습니다: 18,934�(2023-08-24� 부여된 PRSU) � 27,966�(2024-08-26� 부여된 PRSU). 신고서에� PRSU가 1대1 비율� 보통주로 전환된다� 명시되어 있습니다. 보유자 또한 주당 $13.1023,293주를 처분� 사실� 신고했습니다. 신고� 거래 이후 해당 양식에 신고인이 직접 151,923주를 실질적으� 보유하고 있 것으� 기재되어 있습니다. 해당 문서� Julie Boyster� 대신한 위임�(대리인)� 의해 서명되었습니�.

Julie Boyster, identifiée comme Officer (Chief Marketing Officer), a déclaré des opérations au titre de la Section 16 pour Lifevantage Corp (LFVN) le 08/31/2025. Deux attributions de Performance Restricted Stock Units (PRSUs) ont été converties ou ont vesté, entraînant des acquisitions de : 18 934 actions (d’une PRSU attribuée le 24/08/2023) et 27 966 actions (d’une PRSU attribuée le 26/08/2024). Le dossier indique que les PRSU se convertissent en actions ordinaires au taux d’un pour un. La titulaire a également déclaré la cession de 23 293 actions au prix de $13.10 chacune. À la suite des opérations rapportées, le formulaire indique que la personne déclarante détenait directement 151 923 actions. Le document est signé par un mandataire au nom de Julie Boyster.

Julie Boyster, ausgewiesen als Officer (Chief Marketing Officer), meldete am 08/31/2025 Section�16‑Transaktionen für Lifevantage Corp (LFVN). Zwei Zuteilungen von Performance Restricted Stock Units (PRSUs) wurden umgewandelt oder sind vestet und führten zu Erwerbungen von 18.934 Aktien (aus einer PRSU‑Zuteilung am 08/24/2023) und 27.966 Aktien (aus einer PRSU‑Zuteilung am 08/26/2024). In der Meldung steht, dass PRSUs im Verhältnis eins zu eins in Stammaktien umgewandelt werden. Die Inhaberin gab außerdem die Veräußerung von 23.293 Aktien zu einem Preis von $13.10 pro Aktie an. Nach den gemeldeten Transaktionen weist das Formular aus, dass die meldepflichtige Person direkt 151.923 Aktien wirtschaftlich besitzt. Das Formular wurde durch eine Vollmacht im Namen von Julie Boyster unterzeichnet.

Positive
  • Performance-based compensation vested: PRSUs from 08/24/2023 and 08/26/2024 converted into 18,934 and 27,966 common shares respectively, indicating achievement of vesting criteria.
  • One-for-one conversion: The PRSUs convert into common stock on a 1:1 basis, making the equity impact straightforward and transparent.
Negative
  • Insider sale: Reporting person disposed of 23,293 shares at $13.10, reducing direct holdings.
  • Partial reduction in immediately held shares: Despite vesting, the sale reduces available direct ownership relative to gross acquisitions.

Insights

TL;DR: Officer vested performance-based equity and sold a portion of holdings; shows routine insider compensation realization, not necessarily signaling corporate change.

The filing documents that performance-restricted stock units granted in 2023 and 2024 vested or converted on 08/31/2025 into 18,934 and 27,966 common shares respectively, reflecting compensation tied to time and financial targets. These PRSUs convert one-for-one to common stock, aligning executive pay with shareholder equity. The sale of 23,293 shares at $13.10 is a direct disposition reducing on-hand shares. From a governance perspective, these are standard actions: equity vesting as earned and partial monetization by the executive. No regulatory or governance red flags are apparent within the form's disclosures.

TL;DR: Insider received ~46,900 shares via vested PRSUs and sold ~23,300 shares; net increase in holdings remains positive per the filing.

The report shows acquisitions through vesting of PRSUs totaling 46,900 shares (18,934 + 27,966) and a contemporaneous disposition of 23,293 shares at $13.10. The conversion mechanics are one-for-one, simplifying share count impact. The filing lists 151,923 shares beneficially owned after these transactions. These movements alter insider supply but reflect compensation realization rather than an unusual trading pattern based on the disclosed data.

Julie Boyster, indicata come Officer (Chief Marketing Officer), ha segnalato operazioni ai sensi della Section 16 per Lifevantage Corp (LFVN) in data 08/31/2025. Due concessioni di Performance Restricted Stock Units (PRSUs) sono state convertite o sono maturate, determinando acquisizioni di: 18.934 azioni (da una PRSU concessa il 08/24/2023) e 27.966 azioni (da una PRSU concessa il 08/26/2024). Il modulo indica che le PRSU si convertono in azioni ordinarie al rapporto di uno a uno. La titolare ha inoltre segnalato la cessione di 23.293 azioni a un prezzo di $13.10 ciascuna. A seguito delle operazioni riportate, il modulo mostra che la persona che effettua la segnalazione possedeva direttamente 151.923 azioni. Il documento è firmato da un procuratore per conto di Julie Boyster.

Julie Boyster, identificada como Officer (Chief Marketing Officer), informó transacciones bajo la Section 16 en Lifevantage Corp (LFVN) el 08/31/2025. Dos concesiones de Performance Restricted Stock Units (PRSUs) se convirtieron o vencieron, resultando en adquisiciones de: 18.934 acciones (de una PRSU otorgada el 08/24/2023) y 27.966 acciones (de una PRSU otorgada el 08/26/2024). La declaración indica que las PRSU se convierten en acciones ordinarias en una proporción de uno a uno. La titular también reportó una disposición de 23.293 acciones a un precio de $13.10 cada una. Tras las transacciones notificadas, el formulario muestra que la persona informante poseía directamente 151.923 acciones. El formulario está firmado por un apoderado en nombre de Julie Boyster.

Julie BoysterOfficer (Chief Marketing Officer)� 확인되었으며, 08/31/2025� Lifevantage Corp (LFVN)� 대� Section 16 거래� 신고했습니다. � 건의 퍼포먼스 제한 주식 단위(PRSUs)가 전환되거� 베스팅되� 다음� 같은 취득� 발생했습니다: 18,934�(2023-08-24� 부여된 PRSU) � 27,966�(2024-08-26� 부여된 PRSU). 신고서에� PRSU가 1대1 비율� 보통주로 전환된다� 명시되어 있습니다. 보유자 또한 주당 $13.1023,293주를 처분� 사실� 신고했습니다. 신고� 거래 이후 해당 양식에 신고인이 직접 151,923주를 실질적으� 보유하고 있 것으� 기재되어 있습니다. 해당 문서� Julie Boyster� 대신한 위임�(대리인)� 의해 서명되었습니�.

Julie Boyster, identifiée comme Officer (Chief Marketing Officer), a déclaré des opérations au titre de la Section 16 pour Lifevantage Corp (LFVN) le 08/31/2025. Deux attributions de Performance Restricted Stock Units (PRSUs) ont été converties ou ont vesté, entraînant des acquisitions de : 18 934 actions (d’une PRSU attribuée le 24/08/2023) et 27 966 actions (d’une PRSU attribuée le 26/08/2024). Le dossier indique que les PRSU se convertissent en actions ordinaires au taux d’un pour un. La titulaire a également déclaré la cession de 23 293 actions au prix de $13.10 chacune. À la suite des opérations rapportées, le formulaire indique que la personne déclarante détenait directement 151 923 actions. Le document est signé par un mandataire au nom de Julie Boyster.

Julie Boyster, ausgewiesen als Officer (Chief Marketing Officer), meldete am 08/31/2025 Section�16‑Transaktionen für Lifevantage Corp (LFVN). Zwei Zuteilungen von Performance Restricted Stock Units (PRSUs) wurden umgewandelt oder sind vestet und führten zu Erwerbungen von 18.934 Aktien (aus einer PRSU‑Zuteilung am 08/24/2023) und 27.966 Aktien (aus einer PRSU‑Zuteilung am 08/26/2024). In der Meldung steht, dass PRSUs im Verhältnis eins zu eins in Stammaktien umgewandelt werden. Die Inhaberin gab außerdem die Veräußerung von 23.293 Aktien zu einem Preis von $13.10 pro Aktie an. Nach den gemeldeten Transaktionen weist das Formular aus, dass die meldepflichtige Person direkt 151.923 Aktien wirtschaftlich besitzt. Das Formular wurde durch eine Vollmacht im Namen von Julie Boyster unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Boyster Julie

(Last) (First) (Middle)
3300 TRIUMPH BLVD, SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Marketing Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/31/2025 M 18,934(1) A $0 147,250 D
Common Stock 08/31/2025 M 27,966(2) A $0 175,216 D
Common Stock 08/31/2025 F 23,293 D $13.1 151,923 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Restricted Stock Units (3) 08/31/2025 M 18,934 (1) (1) Common Stock 18,934 $0 6,312 D
Performance Restricted Stock Units (3) 08/31/2025 M 27,966 (2) (2) Common Stock 27,966 $0 13,983 D
Explanation of Responses:
1. On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria.
2. On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria.
3. PRSUs convert into common stock on a one-for-one basis.
Remarks:
/s/ Alissa Neufeld, Power of Attorney for Julie Boyster 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Julie Boyster report on Form 4 for LFVN?

The filing reports vesting/conversion of PRSUs into 18,934 and 27,966 common shares and a sale of 23,293 shares at $13.10 on 08/31/2025.

How do the reported PRSUs convert to common stock?

The form states the Performance Restricted Stock Units convert into common stock on a one-for-one basis.

What was the reporting person's role at Lifevantage (LFVN)?

The reporting person is listed as an Officer with the title Chief Marketing Officer.

How many shares did the reporting person beneficially own after the transactions?

Following the reported transactions, the filing shows the reporting person beneficially owned 151,923 shares directly.

When were the PRSUs originally granted that vested in this filing?

The PRSUs were granted on 08/24/2023 (resulting in 18,934 shares) and 08/26/2024 (resulting in 27,966 shares).

Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

164.91M
10.43M
15.23%
65.86%
18.78%
Packaged Foods
Pharmaceutical Preparations
United States
LEHI